Merrimack Pharmaceuticals' Growth Equity Round

Merrimack Pharmaceuticals raised a round of funding on April 19, 2011.

Merrimack Pharmaceuticals (NASDAQ: MACK) is a biopharmaceutical company discovering, developing, and commercializing medicines paired with companion diagnostics for the treatment of serious diseases, …

Articles about Merrimack Pharmaceuticals' Growth Equity Round: